Propyl gallate (E310) has, until recently, been used as a major antioxidant in fatty food and, in the cosmetic industry, in the manufacture of lipsticks. Propyl gallate has a high sensitizing potential; however, the frequency of allergic contact dermatitis from antioxidants of the gallate type was previously thought to be surprisingly low. Previous exposure and orally induced tolerance, as suggested by Khan and colleagues, may have explained the low rates of allergic contact dermatitis to propyl gallate in the past. The objectives were to assess the prevalence of allergic contact dermatitis to propyl gallate in our centre from 1988 to 2005. From 1988 to 2005, 9529 patients were patch tested to the face series, 6973 were females and 2556 were males. Patch tests were read at 2 D and 4 D. Positive reactions were scored as per International Contact Dermatitis Research Group recommendations as negative, +, ++, and +++ reactions. Propyl gallate was used at a 1% petrolatum (pet.). A total of 55 patients had positive reactions to propyl gallate 1% pet. (0.57%), 46 were female (0.65%) and 9 were male (0.33%). Using chi-square, there was a significant difference (P < 0.05) in the positivity rates between the 1988-96 period (0.45%) and the 1997-2005 period (0.77%). A review of our face series performed in the last 18 years has shown a statistically significant increase in propyl gallate-positive rates on patch testing over the last decade. An increase in its use in the cosmetic industry may well be the explanation for this. Nevertheless, a concomitant reduction of propyl gallate as an antioxidant in food, with oral tolerance being less likely to develop, may also be a contributing factor in the increasing trend of allergic contact dermatitis caused by propyl gallate.

221References 1 Velanovich V. Ectopic breast tissue, supernumerary breasts, and supernumerary nipples. South Med J 1995; 88: 903-906. 2 Evans DM, Guyton DP. Carcinoma of the axillary breast. J Surg Oncol 1995; 59: 190-195. 3 Routiot T, Marchal C, Verhaeghe JL et al. Breast carcinoma located in ectopic breast tissue: a case report and review of the literature. Oncol Rep 1998; 5: 413-417. 4 Pfeifer JD, Barr RJ, Wick MR. Ectopic breast tissue and breast-like sweat gland metaplasias: an overlapping spectrum of lesions. J Cutan Pathol 1999; 26: 190-196. 5 Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol 1995; 8: 897-901. 6 Lukowsky A, Muche JM, Sterry W et al. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T-cell receptor-gamma polymerase chain reaction assays. J Invest Dermatol 2000; 115: 254-259. 7 Kao GF, Graham JH, Helwig EB. Paget's disease of the ectopic breast with an underlying intraductal carcinoma: report of a case. J Cutan Pathol 1986; 13: 59-66. 8 Roorda AK, Hansen JP, Rider JA et al. Ectopic breast cancer: special treatment considerations in the postmenopausal patient. Breast J 2002; 8: 286-289. 9 Busam KJ, Tan LK, Granter SR et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol 1999; 12: 786-793. 10 Kaptain S, Tan LK, Chen B. Her-2/neu and breast cancer. Diagn Mol Pathol 2001; 10: 139-152. 11 Wick MR, Ockner DM, Mills SE et al. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.whereas other parts of the tattoo remained unaffected. This indicates that viral inoculation probably took place during the second session, although the transmission of poxvirus could have been either via fomites, or contamination of the ink used for tattooing.

Fig. 1. Skin-positive reaction ++ of the patch test with Nolotil 1 at the site where the fixed drug eruption lesion first appeared.